ATCC, the premier global biological materials resource and standards organization, announces today that it licensed CRISPR/Cas9 gene editing technology from the Broad Institute of MIT and Harvard. ATCC plans to use the gene editing technology to develop a portfolio of new products and services to support basic and translational research.
{iframe}http://www.atcc.org/en/About/News_and_Events/Press_Releases/2016/ATCC_CRISPR_Technology.aspx{/iframe}